Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.57 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.57 |
| ▸ | TACR2 | P21452 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | SHBG | P04278 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.57 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.57 |
| ▸ | HTR2C | P28335 | 1/20 | 0.57 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | TST | Q16762 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19029843 | 1.00 | ESR1 (0.57) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL1876234 | 1.00 | ESR1 (0.57) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL6067892 | 1.00 | ESR1 (0.57) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL1884477 | 1.00 | ESR1 (0.57) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL177373 | 1.00 | ESR1 (0.57) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL11811560 | 1.00 | ESR1 (0.57) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL2120077 | 1.00 | ESR1 (0.57) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL9026740 | 1.00 | ESR1 (0.57) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL20594193 | 1.00 | ESR1 (0.57) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL11435136 | 1.00 | ESR1 (0.57) | ESR1ADRA2AADORA3TACR2SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7934888-B2 | Marine anti-foulant system and methods for using same | VIV SUPPRESSION, INC. (US) | 2011-05-03 | — | — | US | claimed |
| US-20090185867-A1 | MARINE ANTI-FOULANT SYSTEM AND METHODS FOR USING SAME | ASSET INTEGRITY MANAGEMENT SOLUTIONS, L.L.C., D/B/A AIMS INTERNATIONAL | 2009-07-23 | — | — | US | claimed |
| CN-110753694-B | Aldiminosilanes | SIKA技术股份公司 | 2023-07-14 | — | — | CN | disclosed |
| US-11535694-B2 | Latent curing agent and curable polyurethane composition | SIKA TECHNOLOGY AG (CH) | 2022-12-27 | — | — | US | disclosed |
| CN-110770272-B | Latent curing agent and curable polyurethane composition | SIKA技术股份公司 | 2022-03-29 | — | — | CN | disclosed |
| EP-3642252-B1 | LATENT CURING AGENT AND CURABLE POLYURETHANE COMPOSITION | SIKA TECH AG (CH) | 2021-12-08 | — | — | EP | disclosed |
| CN-107922571-B | Antifouling composition | 巴斯夫聚氨酯特种产品（中国）有限公司 | 2021-04-30 | — | — | CN | disclosed |
| US-10941164-B2 | Aldiminosilanes | SIKA TECHNOLOGY AG (CH) | 2021-03-09 | — | — | US | disclosed |
| US-10829636-B2 | Antifouling composition | BASF SE (DE) | 2020-11-10 | — | — | US | disclosed |
| US-20200148707-A1 | ALDIMINOSILANES | SIKA TECHNOLOGY AG (CH) | 2020-05-14 | — | — | US | disclosed |
| US-20200140599-A1 | LATENT CURING AGENT AND CURABLE POLYURETHANE COMPOSITION | SIKA TECHNOLOGY AG (CH) | 2020-05-07 | — | — | US | disclosed |
| EP-0225602-B1 | ALPHA-HYDROXYTHIO ETHERS | CIBA-GEIGY AG (CH) | 1991-10-09 | — | — | EP | disclosed |
| EP-0228045-B1 | AROMATIC THIOETHERS | CIBA-GEIGY AG (CH) | 1991-04-03 | — | — | EP | disclosed |
| US-4808572-A | ANTIALLERGENS | CIBA-GEIGY CORPORATION (US) | 1989-02-28 | — | — | US | disclosed |
| US-4785004-A | ANTIALLERGENS, ANTIHISTAMINES | CIBA-GEIGY CORPORATION (US) | 1988-11-15 | — | — | US | disclosed |
| EP-0123543-B1 | LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION AND USE AND COMPOSITIONS CONTAINING THEM | MERCK FROSST CANADA INC. (CA) | 1988-02-03 | — | — | EP | disclosed |
| EP-0228045-A2 | Aromatic thioethers | CIBA-GEIGY AG (CH) | 1987-07-08 | — | — | EP | disclosed |
| EP-0225602-A2 | Alpha-hydroxythio ethers | CIBA-GEIGY AG (CH) | 1987-06-16 | — | — | EP | disclosed |
| US-4609744-A | 4-oxo-benzopyran carboxylic acids | MERCK FROSST CANADA INC. (CA) | 1986-09-02 | — | — | US | disclosed |
| EP-0123543-A1 | Leukotriene antagonists, their production and use and compositions containing them | MERCK FROSST CANADA INC. (CA) | 1984-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11535694-B2 | Latent curing agent and curable polyurethane composition | RCC1, INCENP, MCM7 | ESR1 2235/4885ADRA2A 3378/4885ADORA3 4766/4885 |
| US-10941164-B2 | Aldiminosilanes | ICAM1, ADH1C, ADH1A | ESR1 2484/4885ADRA2A 1493/4885ADORA3 2212/4885 |
| US-20200148707-A1 | ALDIMINOSILANES | ICAM1, ADH1C, ADH1A | ESR1 2484/4885ADRA2A 1493/4885ADORA3 2212/4885 |
| US-20200140599-A1 | LATENT CURING AGENT AND CURABLE POLYURETHANE COMPOSITION | RCC1, INCENP, MCM7 | ESR1 2235/4885ADRA2A 3378/4885ADORA3 4766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.